Navigation Links
Genes Influence Whether Psych Drugs Lead to Weight Gain
Date:7/20/2012

FRIDAY, July 20 (HealthDay News) -- Researchers have discovered two genetic variants associated with substantial, rapid weight gain in people taking antipsychotic medications.

The researchers said the findings could eventually be used by doctors to identify which patients have the variations so they can be treated without the risk of weight gain, which can lead to obesity and health problems including diabetes and heart disease.

"Weight gain occurs in up to 40 percent of patients taking medications called second-generation or atypical antipsychotics, which are used because they're effective in controlling the major symptoms of schizophrenia," Dr. James Kennedy, of the Center for Addiction and Mental Health, in Toronto, said in a center news release.

Kennedy, senior author of a study published online recently in the journal Archives of General Psychiatry, pinpointed a variation near the melanocortin-4 receptor gene, which is known to be linked to obesity.

The study of patients in Europe and the United States being treated with atypical antipsychotics found that those with two copies of the variant gained about three times as much weight as those with one or no copies -- about 13 pounds vs. 4 pounds.

"The weight gain was associated with this genetic variation in all these groups, which included pediatric patients with severe behavior or mood problems, and patients with schizophrenia experiencing a first episode or who did not respond to other antipsychotic treatments," Dr. Daniel Muller, study co-author and Center for Addiction and Mental Health scientist, said in the news release.

"The results from our genetic analysis combined with this diverse set of patients provide compelling evidence for the role of this [melanocortin-4 receptor] variant," Muller said. "Our research group has discovered other gene variants associated with antipsychotic-induced weight gain in the past, but this one appears to be the most compelling finding thus far."

Kennedy and Muller also were involved in another study that identified a different variation near the melanocortin-4 receptor gene that was associated with weight gain in patients taking antipsychotic drugs. The study was published earlier this year in The Pharmacogenomics Journal.

Although the researchers found that the melanocortin-4 receptor gene variant was associated with rapid weight gain, the study did not prove a cause-and-effect relationship.

More information

The U.S. National Institute of Mental Health has more about mental-health medications.

-- Robert Preidt

SOURCE: Center for Addiction and Mental Health, news release, July 17, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. More Genes Linked to Osteoarthritis Identified
2. Study finds genes associated with hippocampal atrophy
3. New mechanism of bacterial pathogenesis discovered
4. Genes May Influence Reactions to Painkillers
5. Genes Might Help Some Smokers Kick the Habit
6. Genes predict if medication can help you quit smoking
7. Obesity genes may influence food choices, eating patterns
8. Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk
9. Strategy discovered to activate genes that suppress tumors and inhibit cancer
10. Genes Might Be Key to Parkinsons Spread
11. Living longer - variability in infection-fighting genes can be a boon for male survival
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genes Influence Whether Psych Drugs Lead to Weight Gain
(Date:3/28/2017)... (PRWEB) , ... March 28, ... ... a non-profit medical society dedicated to advancing the science and clinical practice ... from its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize ...
(Date:3/28/2017)... ... ... Alert Sentry Group LLC., a leader in the Personal Emergency Response System industry, introduced ... Plus. These iSAFE products are the most affordable and most advanced medical alert systems ... direct GPS Location and two-way calling with the push of a button on a ...
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. ... , Medical doctors and PhD scientists will speak to the press on behalf of ... support of an independent vaccine safety commission. , WHERE: , Zenger Room, National ...
(Date:3/28/2017)... , ... March 28, 2017 , ... The Radiology ... FRBMA, has begun to serve as its new executive director. Mr. Still was selected ... Search Committee. , “Bob, as he is known to our members, has been ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical ... begin serving as new board chair for Orange County health care system CalOptima ... remainder of soon-to-be former chair Mark Refowitz’s term, which runs through June 30 ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... the fourth quarter and year ended December 31, 2016. ... transformational progress for Orexigen, beginning with the re-acquisition of ... early March, the team at Orexigen demonstrated remarkable focus, ... reshaped and strengthened our Company while rewarding us full ...
(Date:3/28/2017)... 2017 The global market for ... the top three companies, namely Shimadzu Corporation, Thermo Fisher ... 49% of the overall market in 2015, observes Transparency ... is intensely competitive and has few players, most of ... factors have restricted the entry of new players in ...
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 /PRNewswire/ ... Israel . This new business entity, Emosis Ltd, headquartered ... to research and development of novel assays complementing the mother company ... relevant, locally support commercialization and sales development of Emosis kits. ... This strategic move starts ...
Breaking Medicine Technology: